| Title | Human Gene Therapy |
| Abbreviation | Hum. Gene Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2) |
| h-index | 153 |
| Overall Rank/Ranking | 3215 |
| SCImago Journal Rank (SJR) | 1.163 |
| Impact Score | 3.57 |
| Publisher | Mary Ann Liebert Inc. |
| Country | United States |
| ISSN | 10430342, 15577422 |
Human Gene Therapy is a journal covering the technologies/fields/categories related to Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2). It is published by Mary Ann Liebert Inc.. The overall rank of Human Gene Therapy is 3215. According to SCImago Journal Rank (SJR), this journal is ranked 1.163. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 153. The best quartile for this journal is Q2.
The ISSN of Human Gene Therapy journal is 10430342, 15577422. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Human Gene Therapy is cited by a total of 1839 articles during the last 3 years (Preceding 2021).
The impact score (IS) 2021 of Human Gene Therapy is 3.57, which is computed in 2022 as per its definition. Human Gene Therapy IS is decreased by a factor of 0.86 and approximate percentage change is -19.41% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2021 of Human Gene Therapy is 3.57. If the same downward trend persists, impact score may fall in 2022 as well.
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 3.57 |
| 2020 | 4.43 |
| 2019 | 3.71 |
| 2018 | 3.30 |
| 2017 | 3.85 |
| 2016 | 3.57 |
| 2015 | 3.71 |
| 2014 | 3.61 |
Human Gene Therapy has an h-index of 153. It means 153 articles of this journal have more than 153 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Human Gene Therapy is 10430342, 15577422. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Human Gene Therapy is 3215. According to SCImago Journal Rank (SJR), this journal is ranked 1.163. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Human Gene Therapy is published by Mary Ann Liebert Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1990-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Human Gene Therapy is Hum. Gene Ther.. This abbreviation ('Hum. Gene Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Logic and Logical Philosophy | journal | 6143 | Nicolaus Copernicus University | 10 | 1.09 |
| Journal of the Geodetic Society of Japan | journal | 25595 | Geodetic Society of Japan | 15 | 0.00 |
| JAMMI | journal | 7141 | University of Toronto Press | 5 | 2.19 |
| Veterinary Record Open | journal | 10706 | John Wiley & Sons Inc. | 14 | 1.55 |
| Organization | journal | 1557 | SAGE Publications Ltd | 104 | 3.98 |
| Tribology Letters | journal | 4762 | Springer New York | 97 | 3.16 |
| Claridades | journal | 25897 | Universidad de Malaga | 1 | 0.04 |
| Pravara Medical Review | journal | 19163 | Deemed University | 5 | 0.30 |
| Oriente Moderno | journal | 24320 | Brill Academic Publishers | 9 | 0.12 |
| Machines | journal | 9564 | MDPI AG | 22 | 3.45 |
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 3.57 |
| 2020 | 4.43 |
| 2019 | 3.71 |
| 2018 | 3.30 |
| 2017 | 3.85 |
| 2016 | 3.57 |
| 2015 | 3.71 |
| 2014 | 3.61 |
3.57
153
3215
1.163
